All Stories

  1. Treatment non-adherence in pseudo-refractory epilepsy
  2. Contraception for women with epilepsy: counseling, choices, and concerns
  3. Interactions between hormonal contraception and antiepileptic drugs: Clinical and mechanistic considerations
  4. In response: Nonadherence to treatment causing acute hospitalizations in people with epilepsy: An observational, prospective study
  5. Frequencies of UGT1A4*2 (P24T) and *3 (L48V) and their effects on serum concentrations of lamotrigine
  6. Nonadherence to treatment causing acute hospitalizations in people with epilepsy: An observational, prospective study
  7. New antiepileptic drugs and women
  8. Is dietary caffeine involved in seizure precipitation?
  9. Second-generation antiepileptic drugs and pregnancy: a guide for clinicians
  10. Relating fatty acid composition in human fingertip blood to age, gender, nationality andn-3 supplementation in the Scandinavian population
  11. Benzoylated Uronic Acid Building Blocks and Synthesis of N-Uronate Conjugates of Lamotrigine
  12. Antiepileptika og førerkort - nye retningslinjer bør revideres
  13. Lamotrigine and its N2-glucuronide during pregnancy: The significance of renal clearance and estradiol
  14. Dekker rusmiddeltester i urin de aktuelle misbruksstoffene?
  15. Expression of UDP-glucuronosyltransferase 1A4 in human placenta at term
  16. Ett antibiotika? Flere antibiotiker? Antibiotikaer?
  17. Dosering av digitoksin i klinisk praksis
  18. Serum concentration/dose ratio of topiramate during pregnancy
  19. Trends and changes in the clinical use of lamotrigine
  20. Seizure control and pharmacokinetics of antiepileptic drugs in pregnant women with epilepsy
  21. Serum concentration/dose ratio of levetiracetam before, during and after pregnancy
  22. Acute Lamotrigine Overdose in an Adolescent
  23. Lamotrigine in children and adolescents: the impact of age on its serum concentrations and on the extent of drug interactions
  24. Combined Overdose of Atomoxetine and Methylphenidate in a Cytochrome P450 2D6 Poor Metabolizer
  25. Lamotrigine Serum Concentrations Throughout the Menstrual Cycle-A Study of 2 Cases
  26. Adverse drug reactions of antidepressants and antipsychotics: Experience, knowledge and attitudes among Norwegian psychiatrists
  27. Ethinyl Estradiol, Not Progestogens, Reduces Lamotrigine Serum Concentrations
  28. Drug Interactions Between Lamotrigine and Psychoactive Drugs
  29. Declaration of Fructose and Fructose-Related Adverse Effects in Commercial Drug Preparations in European Countries
  30. Reduction of MS-related scotomata by a new class of potassium channel blockers from Ruta graveolens